EP 1171158 A2 20020116 - VACCINE COMPRISING RSV ANTIGEN AND CPG OLIGONUCLEOTIDE
Title (en)
VACCINE COMPRISING RSV ANTIGEN AND CPG OLIGONUCLEOTIDE
Title (de)
IMPFSTOFF ENTHALTEND RSV ANTIGEN UND CPG OLIGONUKLEOTID
Title (fr)
VACCIN
Publication
Application
Priority
- EP 0003516 W 20000417
- GB 9909077 A 19990420
- GB 9915106 A 19990628
Abstract (en)
[origin: WO0062802A2] The invention relates to a vaccine formulation comprising a Respiratory Syncytial Virus (RSV) antigen and an immunostimulatory CpG oligonucleotide, to methods of preparing the vaccine formulation and to its use in medicine. Further antigens may be included to provide new combination vaccines for administration to children, to adults and to the elderly.
IPC 1-7
A61K 39/155; A61K 39/39; A61K 39/295; A61P 31/14; A61P 31/04
IPC 8 full level
A61K 39/155 (2006.01); A61K 39/295 (2006.01); A61P 31/12 (2006.01)
CPC (source: EP)
A61K 39/092 (2013.01); A61K 39/12 (2013.01); A61K 39/155 (2013.01); A61K 39/39 (2013.01); A61P 31/04 (2017.12); A61P 31/12 (2017.12); A61P 31/14 (2017.12); A61K 2039/55505 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/55572 (2013.01); A61K 2039/57 (2013.01); A61K 2039/6068 (2013.01); A61K 2039/70 (2013.01); C12N 2760/18534 (2013.01)
Citation (search report)
See references of WO 0062802A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0062802 A2 20001026; WO 0062802 A3 20010111; AR 023534 A1 20020904; AU 4552500 A 20001102; AU 762857 B2 20030710; CA 2370708 A1 20001026; CO 5300406 A1 20030731; EP 1171158 A2 20020116; HK 1045099 A1 20021115
DOCDB simple family (application)
EP 0003516 W 20000417; AR P000101807 A 20000418; AU 4552500 A 20000417; CA 2370708 A 20000417; CO 00028931 A 20000419; EP 00926986 A 20000417; HK 02104795 A 20020627